<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mimmun</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская иммунология</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Immunology (Russia)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1563-0625</issn><issn pub-type="epub">2313-741X</issn><publisher><publisher-name>SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15789/1563-0625-ITA-2088</article-id><article-id custom-type="elpub" pub-id-type="custom">mimmun-2088</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Существует ли зависимость экспрессии интегриновых рецепторов иммунными клетками периферической крови больного от длительности существования туберкулемы легкого?</article-title><trans-title-group xml:lang="en"><trans-title>Is there a dependence between expression of integrin receptors by peripheral blood immune cells and duration of tuberculous granuloma existence in the patients?</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3479-9730</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бердюгина</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Berdyugina</surname><given-names>О. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бердюгина Ольга Викторовна – доктор биологических наук, ведущий научный сотрудник лаборатории иммунологии воспаления</p><p>620049, г. Екатеринбург, ул. Первомайская, 106</p></bio><bio xml:lang="en"><p>Berdyugina Olga V., PhD, MD (Biology), Leading Research Associate, Laboratory of Inflammation Immunology</p><p>620049, Yekaterinburg, Pervomayskaya str., 106</p></bio><email xlink:type="simple">berolga73@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУН «Институт иммунологии и физиологии» Уральского отделения Российской академии наук</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Institute of Immunology and Physiology, Ural Branch, Russian Academy of Sciences</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>27</day><month>11</month><year>2020</year></pub-date><volume>22</volume><issue>5</issue><fpage>867</fpage><lpage>878</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Бердюгина О.В., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Бердюгина О.В.</copyright-holder><copyright-holder xml:lang="en">Berdyugina О.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.mimmun.ru/mimmun/article/view/2088">https://www.mimmun.ru/mimmun/article/view/2088</self-uri><abstract><p>Неснижаемое количество больных туберкулезом в последние годы в стране и в мире обусловлено устойчивостью возбудителя и изменением механизмов восприятия бактерии иммунной системой человека, что требует пристального изучения. Слияние клеток между собой в процессе формирования туберкулем включает большое количество адгезивных событий. Показано, что интегрин α1β1 важен для целостности гранулемы во время хронической фазы инфекции. Доказано, что за туберкулемами необходимо осуществлять наблюдение, в том числе с детекцией клеток, экспрессирующих CD11c, так как они поддерживают непрерывное примирование Т-клеток на различных стадиях инфекции. Целью данного исследования стало изучение вопроса: существует ли различие в экспрессии интегриновых рецепторов иммунными клетками периферической крови больного на разных этапах существования туберкулемы легкого? В исследовании приняли участие 38 человек: первая группа (контрольная) из 15 практически здоровых людей; вторая группа из 11 человек с туберкулемами легких; диагноз впервые был установлен за 2-10 месяцев до проведения настоящего исследования; третья группа из 12 человек с туберкулемами легких; диагноз впервые был установлен за 12-219 месяцев до данного исследования. Всем участникам выполнялось общеклиническое исследование крови с использованием анализатора 5 Diff Mythic 22 AL (Cormay, Польша). Маркеры адгезии CD11b, CD11c детектировали на приборе фирмы Beckman Coulter (США) Coulter Epicx XL. Определяли следующие популяции клеток периферической крови: CD14- CD13lowCD11b+, CD14- CD13lowCD11c+, CD14+CD11b+, CD14+CD11c+, CD45+CD3- CD16+CD56+, CD45+CD3- CD16+CD56+CD11b+. Статистическая обработка полученных результатов выполнялась в операционной среде Windows 10 (Microsoft Corp., США), с использованием компьютерной программы Statistica v. 12.5 (StatSoft, США). В качестве критериев оценки различий между сравниваемыми группами использовали Kruskal–Wallis one-way analysis of variance (pk-w) при уровне значимости различий p &lt; 0,017, а также Wald–Wolfowitz test (pw-w) при уровне значимости различий p &lt; 0,05. Дополнительно реализованы кластерный и факторный виды анализа. Исследуя роль β2-интегринов установлено, что они играют важное значение в поддержании существования туберкулезных гранулем. Отличительным для туберкулем легких, выявленных за 0,5 года до исследования стали увеличение общего числа гранулоцитов и гранулоцитов, экспрессирующих CD11b, снижение популяции лимфоцитов, NK-клеток и NK-клеток, экспрессирующих CD11c. Характерными изменениями, наблюдаемыми при изучении периферической крови больных с туберкулемами легких, выявленными за 9,5 лет до исследования были: увеличение популяции лейкоцитов, общего числа моноцитов, а также моноцитов, экспрессирующих CD11b и CD11c.</p></abstract><trans-abstract xml:lang="en"><p>Over recent years, the number of patients with tuberculosis has not decreased in the country and in worldwide. This is due to high resistance of the pathogen and changing mechanisms of bacterial perception by the human immune system thus requiring closer examination of the issue. Cell fusion during the formation of pulmonary tuberculous granuloma involves a large number of adhesive events. Importance of α1β1 integrin has been shown for the granuloma integrity during the chronic phase of infection. It has been proven that pulmonary tuberculous granuloma should be monitored, including with the detection of cells expressing CD11c, since they support the continuous priming of T cells at different stages of infection. The aim of this study was to answer the question, if there is a different expression of integrin receptors by immune cells from the patient’s peripheral blood at different stages of the existence of pulmonary tuberculous granuloma? The study involved 38 people: the first group (control) consisted of 15 practically healthy people; a second group included 11 subjects with pulmonary tuberculous granuloma; the condition was first diagnosed 2 to 10 months before the present study. A third group consisted of 12 patients with pulmonary tuberculous granuloma, with primary diagnosis established 12 to 219 months before this study. All the participants underwent a general clinical blood tests using a 5 Diff Mythic 22 AL analyzer (Cormay, Poland). The adhesion markers CD11b, CD11c were detected with a Coulter Epicx XL instrument (Beckman Coulter, USA). The following peripheral blood cell populations were determined: CD14- CD13lowCD11b+, CD14- CD13lowCD11c+, CD14+CD11b+, CD14+CD11c+, CD45+CD3- CD16+CD56+, CD45+CD3- CD16+CD56+CD11b+. Statistical processing of the results was performed in the Windows 10 operating environment (Microsoft Corp., USA), using Statistica v. 12.5 software (StatSoft, USA). Kruskal–Wallis one-way analysis of variance (pk-w), with differences significant at p &lt; 0.017, as well as the Wald–Wolfowitz test (pw-w) at a significance level of p &lt; 0.05 were used as criteria for assessing differences between the compared groups. In addition, cluster and factor analysis were implemented. When studying the role of β2-integrins, we have found that they play an important role in maintaining the existence of pulmonary tuberculous granuloma. An increase in total number of granulocytes, and CD11b-expressing granulocytes, a decrease in the population of lymphocytes, NK cells and NK cells expressing CD11c proved to be distinctive in cases of pulmonary tuberculous granuloma detected 0.5 years before the study. Characteristic changes observed in the study of peripheral blood in the patients with pulmonary tuberculous granuloma detected 9.5 years before the study were as follows: an increase in the leukocyte population, total monocyte number, as well as CD11band CD11c-expressing monocytes.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>туберкулема</kwd><kwd>периферическая кровь</kwd><kwd>проточная цитометрия</kwd><kwd>CD11b</kwd><kwd>CD11c</kwd><kwd>моноциты</kwd><kwd>нейтрофилы</kwd><kwd>NK-клетки</kwd><kwd>кластерный анализ</kwd><kwd>факторный анализ</kwd></kwd-group><kwd-group xml:lang="en"><kwd>tuberculous granuloma</kwd><kwd>peripheral blood</kwd><kwd>flow cytometry</kwd><kwd>CD11b</kwd><kwd>CD11c</kwd><kwd>monocytes</kwd><kwd>neutrophils</kwd><kwd>NK cells</kwd><kwd>cluster analysis</kwd><kwd>factor analysis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Бердюгина О.В., Ершова А.В. Функционально-метаболические особенности фагоцитов крови при разных формах туберкулезного воспалительного процесса легких. Медицинская иммунология. 2016;18(1):21-32. https://doi.org/10.15789/1563-0625-2016-1-21-32</mixed-citation><mixed-citation xml:lang="en">Berdyugina O.V., Yershova A.V. Functional and metabolic features of blood phagocytes at different forms of tubercular inflammatory process of lungs. Meditsinskaya immunologiya = Medical Immunology (Russia), 2016, Vol. 18, no. 1, pp. 21-32. (In Russ.) doi: 10.15789/1563-0625-2016-1-21-32.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Cassetta L., Baekkevold E.S., Brandau S., Bujko A., Cassatella M.A., Dorhoi A., Krieg C., Lin A., Loré K., Marini O., Pollard J.W., Roussel M., Scapini P., Umansky V., Adema G.J. Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primates. Cancer Immunol Immunother. 2019; 68:687-697. https://doi.org/10.1007/s00262-019-02302-2</mixed-citation><mixed-citation xml:lang="en">Cassetta L., Baekkevold E.S., Brandau S., Bujko A., Cassatella M.A., Dorhoi A., Krieg C., Lin A., Loré K., Marini O., Pollard J.W., Roussel M., Scapini P., Umansky V., Adema G.J. Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primates. Cancer Immunol. Immunother., 2019, Vol. 68, pp. 687-697.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Ernst J.D. Macrophage Receptors for Mycobacterium tuberculosis. Infection and Immunity. 1998; 66(4):1277-1281. https://doi.10.1128/IAI.66.4.1277-1281</mixed-citation><mixed-citation xml:lang="en">Ernst J.D. Macrophage receptors for Mycobacterium tuberculosis. Infect. Immun., 1998, Vol. 66, no. 4, pp. 1277-1281.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Helming L., Gordon S. Molecular mediators of macrophage fusion. Trends Cell Biol. 2009; 19:514-522. https://doi.10.1016/j.tcb.2009.07.005</mixed-citation><mixed-citation xml:lang="en">Helming L., Gordon S. Molecular mediators of macrophage fusion. Trends Cell Biol., 2009, Vol. 19, pp. 514-522.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Hyun Y., Choe Y.H., Park S.A., Kim M. LFA-1 (CD11a/CD18) and Mac-1 (CD11b/CD18) distinctly regulate neutrophil extravasation through hotspots I and II. Exp Mol Med. 2019; 51:1-13. https://doi.org/10.1038/s12276-019-0227-1</mixed-citation><mixed-citation xml:lang="en">Hyun Y., Choe Y.H., Park S.A., Kim M. LFA-1 (CD11a/CD18) and Mac-1 (CD11b/CD18) distinctly regulate neutrophil extravasation through hotspots I and II. Exp. Mol. Med., 2019, Vol. 51, pp. 1-13.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Jawhara S., Pluskota E., Cao W., Plow E.F., Soloviev D.A. Distinct Effects of Integrins αXβ2 and αMβ2 on Leukocyte Subpopulations during Inflammation and Antimicrobial Responses. Infection and Immunity. 2017; 85(1). PMID: 27799334; PMCID: PMC5203657. https://doi.10.1128/iai.00644-16</mixed-citation><mixed-citation xml:lang="en">Jawhara S., Pluskota E., Cao W., Plow E.F., Soloviev D.A. Distinct Effects of Integrins αXβ2 and αMβ2 on leukocyte subpopulations during inflammation and antimicrobial responses. Infect. Immun., 2017, Vol. 85, no. 1, e00644-16. doi: 10.1128/IAI.00644-16.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Martino M., Lodi L., Galli L., Chiappini E. Immune Response to Mycobacterium tuberculosis: A Narrative Review. Front Pediatr. 2019; 7:350. PMID: 31508399; PMCID: PMC6718705. https://doi.10.3389/fped.2019.00350</mixed-citation><mixed-citation xml:lang="en">Martino M., Lodi L., Galli L., Chiappini E. Immune response to Mycobacterium tuberculosis: A narrative review. Front. Pediatr., 2019, Vol. 7, 350. doi: 10.3389/fped.2019.00350.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Norris B.A., Ernst J.D. Mononuclear cell dynamics in M.tuberculosis infection provide opportunities for therapeutic intervention. PLOS Pathogens. 2018; 14(10):e1007154. https://doi.org/10.1371/journal.ppat.1007154</mixed-citation><mixed-citation xml:lang="en">Norris B.A., Ernst J.D. Mononuclear cell dynamics in M. tuberculosis infection provide opportunities for therapeutic intervention. PLOS Pathog., 2018, Vol. 14, no. 10, e1007154. doi: 10.1371/journal.ppat.1007154.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Podolnikova N.P., Kushchayeva Y.S., Wu Y., Faust J., Ugarova T.P. The Role of Integrins αMβ2 (Mac-1, CD11b/CD18) and αDβ2 (CD11d/CD18) in Macrophage Fusion. Am J Pathol. 2016; 186(8):2105-2116. PMID: 27315778; PMCID: PMC4973655. https://doi.10.1016/j.ajpath.2016.04.001</mixed-citation><mixed-citation xml:lang="en">Podolnikova N.P., Kushchayeva Y.S., Wu Y., Faust J., Ugarova T.P. The role of integrins αMβ2 (Mac-1, CD11b/CD18) and αDβ2 (CD11d/CD18) in macrophage fusion. Am. J. Pathol., 2016, Vol. 186, no. 8, pp. 2105-2116.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Sándor N., Lukácsi S., Ungai-Salánki R., Orgován N., Szabó B., Horváth R., Erdei A., Bajtay Z. CD11c/CD18 Dominates Adhesion of Human Monocytes, Macrophages and Dendritic Cells over CD11b/CD18. PLoS One. 2016; 11(9):e0163120. PMID: 27658051; PMCID: PMC5033469. https://doi.10.1371/journal.pone.0163120</mixed-citation><mixed-citation xml:lang="en">Sándor N., Lukácsi S., Ungai-Salánki R., Orgován N., Szabó B., Horváth R., Erdei A., Bajtay Z. CD11c/CD18 dominates adhesion of human monocytes, macrophages and dendritic cells over CD11b/CD18. PLoS ONE, 2016, Vol. 11, no. 9, e0163120. doi: 10.1371/journal.pone.0163120.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Schittenhelm L., Hilkens C.M., Morrison V.L. β2 Integrins As Regulators of Dendritic Cell, Monocyte, and Macrophage Function. Front Immunol. 2017; 8:1866. PMID: 29326724; PMCID: MC5742326. https://doi.10.3389/fimmu.2017.01866</mixed-citation><mixed-citation xml:lang="en">Schittenhelm L., Hilkens C.M., Morrison V.L. β2 Integrins as regulators of dendritic cell, monocyte, and macrophage function. Front. Immunol., 2017, Vol. 8, 1866. doi: 10.3389/fimmu.2017.01866.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Schreiber H.A., Harding J.S., Hunt O., Altamirano C.J., Hulseberg P.D., Stewart D., Fabry Z., Sandor M. Inflammatory dendritic cells migrate in and out of transplanted chronic mycobacterial granulomas in mice. J Clin Invest 2011; 121(10):3902‐3913. https://doi.10.1172/JCI45113</mixed-citation><mixed-citation xml:lang="en">Schreiber H.A., Harding J.S., Hunt O., Altamirano C.J., Hulseberg P.D., Stewart D., Fabry Z., Sandor M. Inflammatory dendritic cells migrate in and out of transplanted chronic mycobacterial granulomas in mice. J. Clin. Invest., 2011, Vol. 121, no. 10, pp. 3902-3913.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Sia J.K., Rengarajan J. Immunology of Mycobacterium tuberculosis Infections. Microbiol Spectr. 2019; 7(4):10.1128/microbiolspec.GPP3-0022-2018. PMID: 31298204; PMCID: PMC6636855. https://doi.10.1128/microbiolspec.GPP3-0022-2018</mixed-citation><mixed-citation xml:lang="en">Sia J.K., Rengarajan J. Immunology of Mycobacterium tuberculosis infections. Microbiol. Spectr., 2019, Vol. 7, no. 4, 10.1128/microbiolspec.GPP3-0022-2018. doi: 10.1128/microbiolspec.GPP3-0022-2018.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Taylor J.L., Bielefeldt-Ohmann H., Pozzi A., Izzo A.A. Lack of alpha-1 integrin alters lesion morphology during pulmonary Mycobacterium tuberculosis infection. Tuberculosis (Edinb). 2008; 88(5):444-52. PMID: 18639492; PMCID: PMC2613756. https://doi.10.1016/j.tube.2008.05.006</mixed-citation><mixed-citation xml:lang="en">Taylor J.L., Bielefeldt-Ohmann H., Pozzi A., Izzo A.A. Lack of alpha-1 integrin alters lesion morphology during pulmonary Mycobacterium tuberculosis infection. Tuberculosis (Edinb)., 2008, Vol. 88, no. 5, pp. 444-452.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Xu S., Wang J., Wang J.H., Springer T.A. How integrins recognize complement iC3b. PNAS. 2017; 114 (13):3403-3408. https://doi.10.1073/pnas.1620881114</mixed-citation><mixed-citation xml:lang="en">Xu S., Wang J., Wang J.H., Springer T.A. How integrins recognize complement iC3b. PNAS, 2017, Vol. 114, no. 13, pp. 3403-3408. doi: 10.1073/pnas.1620881114.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
